Shares of Novavax Inc. NVAX slid 3.09% to $7.83 Wednesday, on what proved to be an all-around mixed trading session for the ...

Novavax Inc. closed 66.14% below its 52-week high of $23.86, which the company reached on June 6th.

Novavax Stock Performance Shares of NVAX stock opened at $8.19 on Wednesday. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of -3.62, a P/E/G ratio of 63.06 and a beta of 2.14.

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

The institutional investor owned 7,954 shares of the biopharmaceutical company’s stock after purchasing an additional 3,917 shares during the quarter. KBC Group NV’s holdings in Novavax were ...

Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.